NUTX vs. AMLX
NUTX (Nutex Health Inc) and AMLX (Amylyx Pharmaceuticals, Inc.) are both stocks. Both are in the Healthcare sector — NUTX in Health Information Services, AMLX in Biotechnology. Over the past 3 years, NUTX returned 34.96%/yr vs -4.58%/yr for AMLX. Their 0.17 correlation means their historical movements had little consistent relationship.
Performance
NUTX vs. AMLX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NUTX achieves a -10.44% return, which is significantly lower than AMLX's 68.13% return.
NUTX
- 1D
- -0.86%
- 1M
- -24.98%
- 6M
- -0.91%
- YTD
- -10.44%
- 1Y
- 75.51%
- 3Y*
- 34.96%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -42.12%
AMLX
- 1D
- -2.12%
- 1M
- 11.17%
- 6M
- 42.13%
- YTD
- 68.13%
- 1Y
- 163.25%
- 3Y*
- -4.58%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -0.73%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $41.59M | $31.68M | $25.94M | |
NUTX Nutex Health Inc | $17.86M | $21.25M | $20.00M |
NUTX vs. AMLX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
NUTX Nutex Health Inc | -10.44% | 419.47% | 17.37% | -90.53% | -81.82% |
AMLX Amylyx Pharmaceuticals, Inc. | 68.13% | 219.58% | -74.32% | -60.16% | 186.88% |
Correlation
The correlation between NUTX and AMLX is 0.14, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.14 |
Correlation (3Y) Balances recent behavior with more history. | 0.16 |
Correlation (All Time) Calculated using the full available price history since Apr 4, 2022 | 0.17 |
Fundamentals
NUTX:
$1.01B
AMLX:
$2.26B
NUTX:
$20.14
AMLX:
-$1.51
NUTX:
$879.95M
AMLX:
$0.00
NUTX:
$417.67M
AMLX:
-$20.10M
NUTX:
$275.94M
AMLX:
-$150.30M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NUTX vs. AMLX — Risk / Return Rank
NUTX
AMLX
NUTX vs. AMLX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nutex Health Inc (NUTX) and Amylyx Pharmaceuticals, Inc. (AMLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NUTX | AMLX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.70 | ||
| Sortino ratioReturn per unit of downside risk | -1.45 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.35 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | 1.37 | 5.03 | -3.66 |
| Martin ratioReturn relative to average drawdown | 2.68 | 10.76 | -8.08 |
Loading charts...
Drawdowns
NUTX vs. AMLX - Drawdown Comparison
The maximum NUTX drawdown since its inception was -99.93%, roughly equal to the maximum AMLX drawdown of -96.04%. Use the drawdown chart below to compare losses from any high point for NUTX and AMLX.
Loading charts...
Drawdown Indicators
| NUTX | AMLX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.93% | -96.04% | -3.89% |
Max Drawdown (1Y)Largest decline over 1 year | -54.32% | -30.61% | -23.71% |
Max Drawdown (3Y)Largest decline over 3 years | -92.39% | -92.80% | +0.41% |
Current DrawdownCurrent decline from peak | -97.54% | -50.38% | -47.16% |
Average DrawdownAverage peak-to-trough decline | -97.19% | -59.30% | -37.89% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 27.59% | 14.27% | +13.32% |
Volatility
NUTX vs. AMLX - Volatility Comparison
Nutex Health Inc (NUTX) and Amylyx Pharmaceuticals, Inc. (AMLX) have volatilities of 15.79% and 15.49%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NUTX | AMLX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.79% | 15.49% | +0.30% |
Volatility (6M)Calculated over the trailing 6-month period | 60.57% | 39.64% | +20.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 91.11% | 61.22% | +29.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 189.30% | 90.71% | +98.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 189.30% | 90.71% | +98.59% |
Dividends
NUTX vs. AMLX - Dividend Comparison
Neither NUTX nor AMLX has paid dividends to shareholders.
Financials
NUTX vs. AMLX - Financials Comparison
This section allows you to compare key financial metrics between Nutex Health Inc and Amylyx Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NUTX and AMLX have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NUTX has higher volatility (15.79%) compared to AMLX (15.49%). In terms of maximum drawdown, NUTX dropped -99.93% vs AMLX's -96.04%.
AMLX currently has the higher Sharpe Ratio (2.51 vs 0.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NUTX and AMLX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer